"Specializing in the diagnosis and treatment of women with gynecologic malignancies, this team of physician specialists balance quality of life with aggressive treatment with a personalized treatment plan using the most advanced clinical methods for diagnosis, surgery and treatment."

During the past decade, Tennessee Valley Gynecologic Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tennessee Valley Gynecologic Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Tennessee Valley Gynecologic Oncology" are "Ovarian Serous Adenocarcinoma" (3 trials), "Primary Peritoneal Serous Adenocarcinoma" (3 trials), "Endometrial Clear Cell Adenocarcinoma" (2 trials), "Endometrial Serous Adenocarcinoma" (2 trials) and "Fallopian Tube Clear Cell Adenocarcinoma" (2 trials). Many other conditions were trialed in "Tennessee Valley Gynecologic Oncology" in a lesser frequency.

Most popular intervention types in "Tennessee Valley Gynecologic Oncology" are "Other" (6 trials), "Drug" (5 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (5 trials), "Paclitaxel" (4 trials), "Laboratory Biomarker Analysis" (3 trials), "Questionnaire Administration" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tennessee Valley Gynecologic Oncology" are 6 trials for "Female" genders.

Currently, there are NaN active trials in "Tennessee Valley Gynecologic Oncology". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tennessee Valley Gynecologic Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tennessee Valley Gynecologic Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".